C 646 - 98%, high purity , CAS No.328968-36-1, Inhibitor of E1A binding protein p300

Item Number
C274682
Grouped product items
SKUSizeAvailabilityPrice Qty
C274682-1mg
1mg
In stock
$9.90
C274682-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$13.90
C274682-25mg
25mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$27.90
C274682-100mg
100mg
In stock
$91.90
C274682-250mg
250mg
In stock
$154.90
C274682-1g
1g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$400.90

Cell-permeable, competitive, selective, potent p300/CBP HAT inhibitor

Basic Description

Synonyms4-[4-[[5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzoic acid | CHEBI:132974 | Q27075626 | BRD-K73383190-001-03-1 | GTPL7004 | 4-(4-{[5-(4,5-dimethyl-2-nitrophenyl)-2-furyl]methylene}-3-methyl-5-oxo-4,5
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsC646 is a potent, cell permeable and selective inhibitor of p300 and CBP (p300/CBP) histone acetyltransferases. Inhibition of p300/CBP by C646 affects the activity of a variety of transcriptional factors such as NF-κB, p53 and MyoD that are associated wit
Storage TempStore at -20°C,Argon charged,Desiccated
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of E1A binding protein p300
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

C646 was used to study the role of p300 in chronic neuropathic pain in rats with chronic constriction injury.

Associated Targets(Human)

EP300 Tchem Histone acetyltransferase p300 (7 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-[(4Z)-4-[[5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl]methylidene]-3-methyl-5-oxopyrazol-1-yl]benzoic acid
INCHI InChI=1S/C24H19N3O6/c1-13-10-20(21(27(31)32)11-14(13)2)22-9-8-18(33-22)12-19-15(3)25-26(23(19)28)17-6-4-16(5-7-17)24(29)30/h4-12H,1-3H3,(H,29,30)/b19-12-
InChi Key HEKJYZZSCQBJGB-UNOMPAQXSA-N
Canonical SMILES CC1=CC(=C(C=C1C)[N+](=O)[O-])C2=CC=C(O2)C=C3C(=NN(C3=O)C4=CC=C(C=C4)C(=O)O)C
Isomeric SMILES CC1=CC(=C(C=C1C)[N+](=O)[O-])C2=CC=C(O2)/C=C\3/C(=NN(C3=O)C4=CC=C(C=C4)C(=O)O)C
PubChem CID 1285941
Molecular Weight 445.42

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

7 results found

Lot NumberCertificate TypeDateItem
K2428177Certificate of AnalysisApr 07, 2024 C274682
L2123473Certificate of AnalysisOct 20, 2022 C274682
L2123474Certificate of AnalysisOct 20, 2022 C274682
L2123475Certificate of AnalysisOct 20, 2022 C274682
L2123476Certificate of AnalysisOct 20, 2022 C274682
L2123071Certificate of AnalysisOct 20, 2022 C274682
L2123072Certificate of AnalysisOct 20, 2022 C274682

Chemical and Physical Properties

SolubilitySoluble in DMSO to 25 mM

Related Documents

References

1. Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA, Crump NT, Hazzalin CA, Liszczak G, Yuan H et al..  (2010)  Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor..  Chem Biol,  17  (5): (471-82).  [PMID:20534345] [10.1021/op500134e]
2. Dekker FJ, van den Bosch T, Martin NI.  (2014)  Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases..  Drug Discov Today,  19  (5): (654-660).  [PMID:24269836] [10.1021/op500134e]
3. van den Bosch T, Boichenko A, Leus NGJ, Ourailidou ME, Wapenaar H, Rotili D, Mai A, Imhof A, Bischoff R, Haisma HJ et al..  (2016)  The histone acetyltransferase p300 inhibitor C646 reduces pro-inflammatory gene expression and inhibits histone deacetylases..  Biochem Pharmacol,  102  (13): (130-140).  [PMID:26718586] [10.1021/op500134e]
4. Dahlin JL, Nelson KM, Strasser JM, Barsyte-Lovejoy D, Szewczyk MM, Organ S, Cuellar M, Singh G, Shrimp JH, Nguyen N et al..  (2017)  Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors..  Nat Commun,  (1): (1527).  [PMID:29142305] [10.1021/op500134e]
5. Sacta MA et al..  (2018)  Gene-specific mechanisms direct glucocorticoid-receptor-driven repression of inflammatory response genes in macrophages..  Elife,    [PMID:29424686]
6. Fischer A et al..  (2017)  Membrane localization of acetylated CNK1 mediates a positive feedback on RAF/ERK signaling..  Sci Adv,  (8): (e1700475).  [PMID:28819643]
7. Butcher NJ et al..  (2020)  Modulation of Human Arylamine N-Acetyltransferase 1 Activity by Lysine Acetylation: Role of p300/CREB-Binding Protein and Sirtuins 1 and 2..  Mol Pharmacol,  98  (2): (88-95).  [PMID:32487734]
8. Bandyopadhaya A et al..  (2017)  NF-?Bp50 and HDAC1 Interaction Is Implicated in the Host Tolerance to Infection Mediated by the Bacterial Quorum Sensing Signal 2-Aminoacetophenone..  Front Microbiol,  (1211).  [PMID:28713342]
9. Hao Y et al..  (2022)  p300 arrests intervertebral disc degeneration by regulating the FOXO3/Sirt1/Wnt/β-catenin axis..  Aging Cell,  21  (8): (e13677).  [PMID:35907249]
10. Wei L et al..  (2019)  Silencing of lncRNA MALAT1 Prevents Inflammatory Injury after Lung Transplant Ischemia-Reperfusion by Downregulation of IL-8 via p300..  Mol Ther Nucleic Acids,  18  (285-297).  [PMID:31604167]
11. Smith ER et al..  (2019)  TGF-ß1 modifies histone acetylation and acetyl-coenzyme A metabolism in renal myofibroblasts..  Am J Physiol Renal Physiol,      [PMID:30623724]
12. Peghaire C et al..  (2019)  The transcription factor ERG regulates a low shear stress-induced anti-thrombotic pathway in the microvasculature..  Nat Commun,  10  (5014).  [PMID:31676784]

Solution Calculators